<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00763217</url>
  </required_header>
  <id_info>
    <org_study_id>CP 05/15</org_study_id>
    <secondary_id>PHRC 2004/1901</secondary_id>
    <nct_id>NCT00763217</nct_id>
  </id_info>
  <brief_title>Clinical Biological and Pharmacological Factors Influencing Stroke Outcome</brief_title>
  <acronym>biostroke</acronym>
  <official_title>Characterization of Clinical, Biological and Pharmacological Markers of Stroke Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a previous suty, we have demonstrated that prior transient ischemic attack, treatment
      lipid-lowering drug or physical activity are associated to a better outcome of stroke. The
      aim of the study is to understand the mechanisms of this preventive neuroprotection by
      establishing link between biomarkers and preventive and neuroprotective measures.To answer to
      the question, we conduct a cohort study of stroke patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the cohort, the severity of stroke (NIHSS) will be correlated with :

        -  clinical factors,

        -  pharmacological factors,

        -  biological factors (inflammatory markers, hemostasis...)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>severity of stroke measured by NIH severity score</measure>
    <time_frame>inclusion, day7, month3, year3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical, pharmacological and biological (metabolic, inflammation, hemostasis...) cognitive status</measure>
    <time_frame>inclusion and year3</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">550</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>stroke patient cohort</arm_group_label>
    <description>Patients with an hemispheric ischemic or hemorrhage stroke hospitalized during the 48h following the beginning of stroke</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood and serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort of stroke patient
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ischemic or hemorrhage stroke

          -  hemispheric stroke

          -  stroke dating from less 48h

        Exclusion Criteria:

          -  non hemispheric stroke

          -  malformative intracranial hemorrhage

          -  traumatic intracranial hemorrhage

          -  subarachnoidal hemorrhage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>regis BORDET, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lille University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lille University Hospital - Service de Neurologie vasculaire</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2008</study_first_submitted>
  <study_first_submitted_qc>September 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2008</study_first_posted>
  <last_update_submitted>May 12, 2015</last_update_submitted>
  <last_update_submitted_qc>May 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>inflammation</keyword>
  <keyword>coagulation</keyword>
  <keyword>neuroprotection</keyword>
  <keyword>drugs</keyword>
  <keyword>clinical neurology</keyword>
  <keyword>pharmacology</keyword>
  <keyword>biological factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

